EQS Newswire is a major provider of regulatory and corporate news. It mainly serves companies, investors and media worldwide. Through its services, EQS Newswire enables efficient and secure communication between companies and their stakeholders. Its main services include the distribution of ad hoc announcements, corporate news and the publication of financial reports that meet strict international standards.
Mon, 27.01.2025
Straumann Holding AG
/ Key word(s): Quarter Results/Sales Result
Invitation to Straumann Group’s FYR 2024 analysts and media conference at Straumann Group Headquarters
27.01.2025 / 15:28 CET/CEST
Date: Wednesday, February 19, 2025
Program:
09:30 a.m. CET Door opening & welcome coffee
10:00 – 11:00 a.m. CET Prese...
Straumann Holding AG
/ Key word(s): Quarter Results/Sales Result
Invitation to Straumann Group’s 2024 full-year results webcast
27.01.2025 / 15:27 CET/CEST
Date: Wednesday, February 19th, 2025
Time: 10:00 – 11:00 a.m. CET
Straumann Group will publish its 2024 full-year results on Wednesday, February 19th, 2025, at app...
Third-quarter revenue amounted to CHF 585.5 million, a strong increase of 11.2% organic growth, bringing revenue in the first nine months to about CHF 1.9 billion
Global launch of intraoral scanner SIRIOS
Continued investments in capacity expansion
Outlook 2024 confirmed: organic revenue growth in the low double-digit percentage range and profit...
Straumann Holding AG
/ Key word(s): 9 Month figures
Invitation: Straumann Group 2024 third-quarter results webcast
16.10.2024 / 10:16 CET/CEST
Date: Tuesday, October 29, 2024
Time: 10:30 – 11:30 a.m. CET
Straumann Group will publish its 2024 third-quarter results on Tuesday, October 29, 2024, at approximately 7:...
Half-year revenue reached CHF 1.3 billion1, growing 16.1%1 organically, achieving CHF 654.9 million1 or 14.8%1 in the second quarter
Core2 EBIT margin at 27.8%1 including currency headwinds, in the first half year
DrSmile to be sold to Impress Group; Straumann Group to keep minority of 20% in the combined entity
Transitions in the Executive Mana...
Straumann Holding AG
/ Key word(s): Half Year Results/Sales Result
Invitation: Straumann Group 2024 half-year results webcast
05.08.2024 / 13:30 CET/CEST
Date: Wednesday, August 14, 2024
Time: 09:30 – 10:30 a.m. CEST
Straumann Group will publish its 2024 half-year results on Wednesday, August 14, 2024, at approximate...
Strong organic revenue growth of 15.1% and first-quarter revenue of CHF 643.8 million
Different regional growth dynamics, with Asia Pacific outperforming
New premium implant system iEXCEL successfully launched in North America
AlliedStar intraoral scanner launched in China
Outlook 2024 confirmed: the Group aims to achieve organic revenue grow...
Straumann Holding AG
/ Key word(s): Quarter Results
Invitation: Straumann Group 2024 first-quarter sales report webcast
18.04.2024 / 08:00 CET/CEST
Date: Tuesday, 30 April, 2024
Time: 10:30 – 11:30 a.m. CEST
Straumann Group will publish its 2024 first-quarter sales report on Tuesday, 30 April, 2024, at approxima...
Straumann Holding AG
/ Key word(s): Quarter Results
Invitation: Straumann Group 2024 first-quarter sales report webcast
18.04.2024 / 08:00 CET/CEST
Date: Tuesday, 30 April, 2024
Time: 10:30 – 11:30 a.m. CEST
Straumann Group will publish its 2024 first-quarter sales report on Tuesday, 30 April, 2024, at approxima...
Straumann Holding AG
/ Key word(s): AGMEGM
Straumann Group shareholders approve all proposals and elect Xiaoqun Clever-Steg and Stefan Meister as new Board Members
12.04.2024 / 13:33 CET/CEST
Basel, 12 April 2024 – Today at the Annual General Meeting (AGM) of Straumann Holding AG, the Straumann shareholders approved a...
You have pressed the "". We would like to inform you that you are now leaving the information service of the portal site ayondo.com. You will be redirected to . After confirming the "Continue" button, you confirm that you have been informed of this. You also confirm that you are carrying out this process of your own free will and that it is not the result of any promotional activity or other influence. Continue to .